Tamsulosin hydrochloride
Based on 2 publication(s) in Google Scholar
Tamsulosin hydrochloride ((R)-(-)-YM12617 free base) is an orally active antagonist of α1-adrenergic receptor. Tamsulosin hydrochloride induces Apoptosis. Tamsulosin hydrochloride is used for the research of prostatic hyperplasia. Tamsulosin hydrochloride attenuates abdominal aortic aneurysm growth and inhibits inflammation in animal models.
For research use only. We do not sell to patients.
- Purity: 99.76%
- CAS No.: 106463-17-6
- Formula: C20H29ClN2O5S
- Molecular Weight:444.97
-
Storage:
4°C, sealed storage, away from moisture and light
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
Publications Citing Use of MedChemExpress (MCE) Tamsulosin hydrochloride
MoreAll Adrenergic Receptor Isoforms
More
Biological Activity
|
α1-adrenergic receptor |
Tamsulosin hydrochloride shows intrinsic activity at human alpha1B adrenergic receptor expressed in CHOK1 cells co-expressing aequorin, with EC50 of 0.13 nM[2].
Tamsulosin (25-50 nM, 24 h) hydrochloride attenuates high glucose-induced injury in glomerular endothelial cells[3].
Tamsulosin (1-100 μM, 5 days) hydrochloride significantly influences ECM production and distribution as well as cellular metabolism levels in ARPE 19 cells in a concentration-dependent manner[4].
.
Tamsulosin (50-400 μM, 24 h) hydrochloride induces apoptosis and clusterin expression in NRP-152 cells[5].
.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:Human glomerular endothelial cells (GECs)
-
Concentration:25, and 50 nM
-
Incubation Time:24 h
-
Result:Attenuated high glucose-induced expression of pro-inflammatory cytokines IL-6, TNF-α, and IL-8.
Reduced MMP-2 and MMP-9.
Prevented high glucose-induced expression of VCAM-1 and ICAM-1.
Decreased Col-1 and TGF-β1.
-
Cell Line:Human glomerular endothelial cells (GECs)
-
Concentration:25, and 50 nM
-
Incubation Time:24 h
-
Result:Decreased nuclear NF-κB p65 to 2.7- and 1.9- fold at 25 and 50 nM, respectively.
Tamsulosin (0.01-1 mg/kg, p.o., once a day for 14 consecutive days) hydrochloride exerts inhibitory effect on neuronal activation in the voiding centers of rats with Cyclophosphamide (HY-17420)-induced overactive bladder[7].
Tamsulosin (17.5-35 mcg/kg/d, p.o.) hydrochloride results in protection from respiratory inflammatory events in rats with induced airway sensitization[8].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 106463-17-6
-
Appearance Solid
-
Molecular Weight 444.97
-
Formula C20H29ClN2O5S
-
Color White to off-white
-
SMILES
O=S(C1=CC(C[C@H](NCCOC2=CC=CC=C2OCC)C)=CC=C1OC)(N)=O.Cl
-
Synonyms
(R)-(-)-YM12617; LY253351
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
4°C, sealed storage, away from moisture and light
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
Publications (2)
-
Journal Impact Factor
-
Most Recent
-
Nat Commun
A gatekeeper sympathetic control of lacrimal tear secretion and dry eye onset through the NA-Adra1a-Ucp2 pathway. [Abstract]2025 Jun 5;16(1):5215. PMID: 40473608 -
Invest Ophthalmol Vis Sci
Activation of Sympathetic Nervous System Drives Dry Eye Onset Via Norepinephrine-β2-Adrenergic Receptor Signaling in Mice. [Abstract]2025 Jun 2;66(6):13. PMID: 40465266
Solvent & Solubility
DMSO : 50 mg/mL (112.37 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Purity & Documentation
-
Data Sheet (279 KB)
-
SDS (392 KB)
- English - EN (392 KB)
- Français - FR (392 KB)
- Deutsch - DE (392 KB)
- Norwegian - NO (392 KB)
- Español - ES (392 KB)
- Swedish - SV (392 KB)
- Italian - IT (392 KB)
- Korean - KR (392 KB)
- Portuguese - PT (392 KB)
-
Handling Instructions (2659 KB)
References
[1]. Christopher Chapple, et al. Tamsulosin: an overview. World J Urol. 2002 Apr;19(6):397-404. [Content Brief]
[2]. Rak A, et al. Arylsulfonamide derivatives of (aryloxy)ethyl pyrrolidines and piperidines as α1-adrenergic receptor antagonist with uro-selective activity. Bioorg Med Chem. 2016 Nov 1;24(21):5582-5591. [Content Brief]
[3]. Sun L, et al. Tamsulosin attenuates high glucose- induced injury in glomerular endothelial cells. Bioengineered. 2021 Dec;12(1):5184-5194. [Content Brief]
[4]. Ida Y, et al. The Selective α1 Antagonist Tamsulosin Alters ECM Distributions and Cellular Metabolic Functions of ARPE 19 Cells in a Concentration-Dependent Manner. Bioengineering (Basel). 2022 Oct 14;9(10):556. [Content Brief]
[6]. Holanda VAD, et al. Tamsulosin facilitates depressive-like behaviors in mice: Involvement of endogenous glucocorticoids. Brain Res Bull. 2022 Jan;178:29-36. [Content Brief]
[7]. Kim SE, et al. Effects of Tamsulosin on Urinary Bladder Function and Neuronal Activity in the Voiding Centers of Rats with Cyclophosphamide-induced Overactive Bladder. Int Neurourol J. 2012 Mar;16(1):13-22. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.2473 mL | 11.2367 mL | 22.4734 mL | 56.1836 mL |
| 5 mM | 0.4495 mL | 2.2473 mL | 4.4947 mL | 11.2367 mL | |
| 10 mM | 0.2247 mL | 1.1237 mL | 2.2473 mL | 5.6184 mL | |
| 15 mM | 0.1498 mL | 0.7491 mL | 1.4982 mL | 3.7456 mL | |
| 20 mM | 0.1124 mL | 0.5618 mL | 1.1237 mL | 2.8092 mL | |
| 25 mM | 0.0899 mL | 0.4495 mL | 0.8989 mL | 2.2473 mL | |
| 30 mM | 0.0749 mL | 0.3746 mL | 0.7491 mL | 1.8728 mL | |
| 40 mM | 0.0562 mL | 0.2809 mL | 0.5618 mL | 1.4046 mL | |
| 50 mM | 0.0449 mL | 0.2247 mL | 0.4495 mL | 1.1237 mL | |
| 60 mM | 0.0375 mL | 0.1873 mL | 0.3746 mL | 0.9364 mL | |
| 80 mM | 0.0281 mL | 0.1405 mL | 0.2809 mL | 0.7023 mL | |
| 100 mM | 0.0225 mL | 0.1124 mL | 0.2247 mL | 0.5618 mL |